| Literature DB >> 28749983 |
Su Keng Tan1,2, Wai Keung Leung3, Alexander Tin Hong Tang4, Roger A Zwahlen2.
Abstract
BACKGROUND: Mandibular advancement surgery may positively affect pharyngeal airways and therefore potentially beneficial to obstructive sleep apnea (OSA).Entities:
Mesh:
Year: 2017 PMID: 28749983 PMCID: PMC5531493 DOI: 10.1371/journal.pone.0181146
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Electronic databases search strategy (refer to S1 Text for detailed search strategy).
| Electronic databases | Search strategy |
|---|---|
| PubMed | (Systematic review OR review OR overview OR meta-analysis OR evidence based medicine OR evidence based dentistry OR review literature OR literature review) |
| EMBASE | AND |
| Web of Science | (orthognathic surgery OR orthognathic surgical procedure OR orthodontics surgery OR maxillomandibular advancement OR mandibular surgery OR maxillary surgery OR bimaxillary surgery OR jaw surgery OR surgical orthodontic treatment OR jaw advancement OR jaw movement OR mandibular advancement) |
| Cochrane library | AND |
| Scopus | (upper airway OR pharynx OR pharyngeal OR oropharynx OR oropharyngeal OR nasopharynx OR nasopharyngeal OR hypopharynx OR hypopharyngeal) |
Fig 1Study selection process.
Characteristics of included articles.
| Authors, year | Type of review | Database searched | Primary studies | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Airway assessed | Included studies | Participants | Patients | Interventions | Outcome measures | Maximum follow-up period | |||||||
| Studies with mandibular advancement /Total number of primary studies | Type | Total number | M/F | Age | Airway parameters | Respiratory parameters | |||||||
| Alsufyani | SR | Medline, EBM | OP; | 4/7 | 1 CS; | 7 | 4/3 | Mean: 43 | SDB/ OSAS | MMA(4) | Total volume, | AHI, | 7 weeks-6 months |
| Caples | MA | (MEDLINE, EMBASE, Current Contents, Cochrane CENTRAL through Ovid) | NR | 9/70 | 9 O | 234 | 9:1 | 43.9 | OSA | MMA (9) | NR | AHI | NR |
| Christovam | MA | Cochrane library, Medline, Scopus, VHL, Web of Science, Open-Grey. | UA | 11/27 | 9 R; | 252 | 102/112 | 22–44.6 | NR | MMA (9); | Cross-sectional area and volume | NR | 5 weeks-1 year |
| Elshaug | MA | Medline | NR | 4/18 | 4 CS | 38 | NR | NR | OSA | MMA (3) | NR | AHI | NR |
| Hsieh and Liao, 2013[ | SR | PubMed | PAS | 15/15 | 15 CS | 376 | 219/ | 33–51 | OSA | MMA (15) | Linear (posterior airway space, airway length); | AHI, | 6 weeks– 21.8 months |
| Holty and Guilleminault, 2010[ | MA | Medline | PAS | 59/59 | CS; | 957 | 836/ | Mean: 44.4±9.4 | OSA | MMA (59) | PAS | AHI, | 3–7.7 months |
| Knudsen | MA | PubMed, Cochrane | PAS | 4/4 | NR | 115 | NR | NR | OSA | MMA (4) | NR | AHI, LSAT | NR |
| Mattos | MA | VHL, Scirus, Ovid, SIGLE. | OP | 5 | 4 R | 135 | 40/83 | 21–36.3 | NR | MdA(3); | Linear | NR | 6 weeks– 12 years |
| Rosario | MA | PubMed, | UA | 7 | CCT | 103 | 47/46 | 22–42.75 | OSA (4); | MMA (7) | Volume | AHI | 2–49 months |
| Pirklbauer | SR | PubMed | NR | 28/28 | 1 RCT | 917 | 561/87 | 41.0–50.3 | OSA | MMA (28) | NR | AHI, | 2–12 months |
| Zaghi | Cochrane library, Scopus, Web of Science, Medline | PAS | 45/45 | 1 RCT | 518 | 282/57 | Mean: 45.3 ±10 | OSA | Linear | AHI, | 2–6 months | ||
# EBM = All evidence-based medicine reviews (EBM), including Cochrane Database
β 2 articles[5, 37] have included both mandibular advancement and setback surgeries.
α Only 6 studies included in the meta-analysis (One study did not report absolute value for average on difference)
δ Meta-analysis was only performed on respiratory parameters only
Abbreviations: SR = systematic review; MA = meta-analysis; NP = nasopharyngeal, OP = oropharyngeal, HP = hypopharyngeal, UA = upper airways, PAS = Posterior airway space; R = Retrospective study; O = Observational, P = Prospective study; CCT = Case controlled trials; Co = Cohort study, CS = Case series; CR = Case report; SDB = Sleep disordered breathing; OSAS = obstructive sleep apnea syndrome; MdA = Mandibular advancement, MMA = Maxillomandibular advancement; MCS area = Minimum cross-sectional area; Ceph = Cephalometric; CT = Computed tomography; CBCT = Cone-beam computed tomography; MRI = magnetic resonance imaging; AHI = Apnea-hypopnea index; RDI = respiratory disturbance index; SpO2nadir = lowest oxyhemoglobin saturation measured during sleep; LSAT = lowest oxygen saturation, NR = not reported
Quality assessment of included systematic reviews with AMSTAR tool.
| AMSTAR criteria | Alsufyani | Hsieh and Liao[ | Pirklbauer | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Was an ‘a priori’ design provided? | CA | CA | Y | CA | CA | CA | CA | Y | Y | CA | CA |
| 2. Was there duplicate study selection and data extraction? | Y | Y | Y | CA | Y | CA | CA | Y | Y | CA | Y |
| 3. Was a comprehensive literature search performed? | Y | Y | Y | N | N | N | Y | Y | Y | N | Y |
| 4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? | N | N | Y | N | N | N | N | Y | N | N | N |
| 5. Was a list of studies (included and excluded) provided? | N | N | N | N | N | Y | N | Y | Y | N | N |
| 6. Were the characteristics of the included studies provided? | Y | Y | Y | N | N | Y | N | Y | Y | Y | Y |
| 7. Was the scientific quality of the included studies assessed and documented? | Y | N | Y | Y | Y | N | N | Y | Y | Y | Y |
| 8. Was the scientific quality of the included studies used appropriately in formulating conclusions? | N | NA | Y | Y | Y | NA | NA | Y | N | Y | N |
| 9. Were the methods used to combine the findings of studies appropriate? | N | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 10. Was the likelihood of publication bias assessed? | N | N | N | N | N | N | N | Y | N | NA | Y |
| 11. Was the conflict of interest stated? | CA | CA | CA | CA | CA | CA | CA | CA | CA | CA | CA |
| 4 | 4 | 8 | 3 | 4 | 3 | 2 | 10 | 7 | 4 | 6 |
*Systematic reviews with meta-analysis;
β Yes, but not complete list of all excluded studies
Abbreviations: Y = yes; N = no; CA = can’t answer; NA = not applicable
Quality assessment for primary studies of included systematic reviews.
| Systematic reviews | Assessment method | Assessment criteria | Scoring method | Result | Remark |
|---|---|---|---|---|---|
| Alsufyani | Risk of bias assessment with customized tool adopted from |
Selection bias Detection or measurement bias Analysis or interpretation bias Performance bias |
High risk of bias (<50%) Moderate risk of bias (50%) Low risk of bias (>50%) |
7 High risk of bias | Pilot testing of the tool was performed. Result mostly due to criteria 1 and 2. |
| Christovam | Risk of bias based on quality assessment method reported by Mattos |
Eligible criteria for participants described Presence of control group Blinding assessment stated Statistical treatment performed Reliability of measures tested Reporting drop-outs Follow-up period reported Potential bias and trial limitations addressed |
Low risk of bias (≥4.5) Moderate risk of bias (>2 and <4.5) High risk of bias (≤2) |
1 Low risk of bias 6 Moderate risk of bias | High risk papers have been excluded from the review |
| Elshaug | Level of evidence | Type of publication |
Level 1: systematic review of or individual randomized, controlled trial or trials (RCT) Level 2: cohort study Level 3: case-control study Level 4: case series Level 5: expert opinion |
4 Level 4 | - |
| Hsieh and Liao, 2013[ | Methodology soundness checklist (modified from Antczak |
Study design Sample size Method of selection Consecutive recruitment Valid methods Consideration of confounding factors Analysis of errors in methods ‘blinding’ in measurement Adequate statistical analysis |
Low quality (≤3) Medium quality (4–7) High quality (8–9) |
10 Low quality 5 Medium quality | - |
| Mattos | Self-compiled criteria for quality of methodological soundness (mostly based on CONSORT statement) | As above (refer Christovam |
High quality (>6 points) Moderate quality (4–6 points) Low quality (<4 points) |
2 Moderate quality | Low research quality of methodological soundness studies were excluded from the review. |
| Priklbauer | Criteria defined by the Oxford Centre of evidence-based medicine |
1a Systematic review of randomized controlled trials 1b Individual randomized controlled trial 2a Systematic review of cohort studies 2b Individual cohort study 3a Systematic review of case control studies 3b Individual case control studies 4 Case series/case report 5 Expert opinion, bench research |
Grade A: level 1a, 1b Grade B: level 2a, 2b, 3a, 3b Grade C: Level 4 Grade D: Level 5 |
1 Grade A 5 Grade B 22 Grade C | - |
| Rosario | Risk of bias across studies (checklist adapted from Cericato |
Clear abstract Clear and precise objective Cited ethical aspects Adequate research design Reported sample size calculation Control group presence Cited statistical methods Clear and precise results Study limitation discussed |
Low quality (0–6 points) Medium quality (7–9 points) High quality (10–12 points) |
1 High quality 6 Moderate quality | 3 low quality articles were excluded |
| Zaghi | Methodology quality assessment questionnaire (self-developed) |
Clinical description and characteristics (4 items) Sleep study test quality Independence of sleep study interpretation Surgical technique quality Sample size Cohort assembly |
1 point for each “yes” 0 point for each “no” Scores 0–10 |
Mean: 5.11±1.43 Median: 5 Range: 2–8 | Larger sample size was not significantly associated with higher quality (p = 0.5102) |
* AHRQ EPC Methods Guide = Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center (EPC) Methods Guide for Effectiveness and Comparative Effectiveness Reviews on assessing the risk of bias of individual studies.
- Quality of primary studies was not assessed or incomplete in three systematic reviews[10, 13, 15]
Results from multiple meta-analyses of MMA procedures reported by included systematic reviews.
| Meta-analyses | Outcome measure(s) | Results | No of studies (No. of patients) |
|---|---|---|---|
| Christovam | mCSA changes | Increased significantly | 3 (29) |
| Total volume changes | Increased significantly | 5 (66) | |
| Mattos | AP changes (soft palate-pharyngeal wall) | Increased significantly (p<0.00001), MD = 3.64mm [95% CI 2.67, 4.61]; I2 = 0% | 2 (88) |
| Rosario | UA volume changes | Increased significantly (p<0.00001), MD = 7.86ml [95% CI 5.47, 10.07]; I2 = 0% | 6 (83) |
| Caples | AHI reduction % | Ratio of means [mean = 0.13; 95% CI 0.08, 0.200]; p<0.00001; | 9 (234) |
| Elshaug | Surgical success rate | 1. 86% [95% CI 0.74, 0.95] for 50% AHI reduction/ AHI ≤ 20/h / both3. | 4 (38) |
| 2. 45% [95% CI 0.30, 0.60] for AHI ≤ 10/h | |||
| 3. 43% [95% CI 0.28, 0.58] for AHI ≤ 5/h | |||
| Holty | AHI changes | Reduced significantly (p<0.001); Mean = 63.9±26.7/h vs 9.5±10.7/h | 22 (627) |
| SpO2 nadir | Increased significantly (p<0.001); Mean = 71.9+14.8% versus 87.7+4.8% | 17 (516) | |
| Surgical success rate | 86% for 50% AHI reduction/ AHI ≤ 20 / both43.2% for AHI<5/h | 22 (627) | |
| 77.6% for AHI < 15/h | |||
| 63.4% for AHI <10/h | |||
| 43.2% for AHI<5/h | |||
| Knudsen | AHI changes | Mean OR = 14.9 [95% CI 2.7, 83.5]; p = 0.002; | 3 (49) |
| Mean OR = 114.8 [95% CI 23.5, 561.1]; p<0.00001; | 4 (59) | ||
| Mean OR = 6.09 [95% CI 2.18, 16.96]; p<0.00001; | 3 (36) | ||
| Zaghi | AHI changes | Reduced significantly (p<0.001), MD = -47.8/h [95% CI ±4.7]; | 36 (455) |
| RDI changes | Reduced significantly (p<0.001), MD = -44.4/h [95% CI ±8.0]; | 11 (68) | |
*The article only reported up to three decimal digits
#The article only described the result in text without figure, thus some data like p-value was missing.
γ 4 cases were mandibular advancement only, other 34 cases were MMA.
Abbreviations: mCSA = minimum cross sectional area; MD = mean difference; UA = upper airway; AHI = apnea-hypopnea index; RDI = respiratory disturbance index; SpO2 nadir = lowest oxyhaemoglaobin saturation measured during sleep; OR = odd ratio
Summary from primary studies of isolated mandibular advancement osteotomies.
| Primary studies | Paticipants | Mean Age | Maximum follow-up period | Imaging method | Main findings |
|---|---|---|---|---|---|
| Archilleos | 20(20:-) | 26.27(17.33–43.58) | PO 3 years | Ceph |
PO 6 months: Significant larger PA (sagittal dimension) at the level of OP (p<0.05) and tongue base (p<0.01) PO 3 years: Significant wider minimum dimension of PA (P<0.05) Long term (3 years) widening of minimal PA space |
| Eggensperger | 15(4:11) | 21(17–31) | PO 12 years | Ceph |
Immediate PO: increased of UP and LP size PO 1 year: MP smaller than pre-op PO 12 years: both UPA and MPA significantly (p<0.05) smaller than pre-op; LPA returned to pre-op value Mandibular advancement surgery alone did not increase pharyngeal airway in long term (12 years) |
| Hernandez-Alfaro | 10 | Mean:PO121.4 days | CBCT | Average PA space volume increase of 78.3% (range: 0.9–167.6%) Mandibular advancement will enlarge PA space volume | |
| Kochel | 102(27:75) | 31.8 | PO 5 weeks | CBCT | PO 5 weeks: Significant increased (p<0.001)
at posterior NP (12.5%), upper OP (38.8%) and lower OP (45.6%) of cross-sectional area at the level of soft palate (48.5%), hard palate (14.6%), epiglottis tip (21.6%) and minimum cross-sectional area (46.9%) of diameters in both sagittal and transversal planes |
| Turnbull | 8 | PO 6 weeks | Ceph |
|
# All isolated mandibular advancement osteotomies here were bilateral sagittal split osteotomies (BSSO).
* Unable to be determined asthe study also involve other groups with different surgical procedures.
Abbreviations: M = male; F = female; Ceph = cephalometric; CBCT = con beam computed tomography; PA = pharyngeal airway; OP = oropharyngx; NP = nasopharynx; UPA = upper pharyngeal airway; MPA = middle pharyngeal airway; LPA = lower pharyngeal airway; pre-op = pre-operative; PO = post-operative.
Fig 2Forest plot of total volumetric changes of pharyngeal airway after MMA.
Fig 3Funnel plot for MMA studies.